MedRespond
MedRespond provides AI-powered conversational patient engagement platforms for hospitals, health systems, clinical trial sponsors, and advocacy groups, enabling patients to ask questions in natural language and receive personalized IRB-approved video responses through its proprietary Synthetic Interview technology.
- Company typePrivate
- Founded2000
- HeadquartersPittsburgh, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What MedRespond does
MedRespond is a privately-held healthcare technology company headquartered in Pittsburgh, Pennsylvania that builds conversational patient engagement platforms for hospitals, health systems, pharmacy retailers, advocacy groups, professional associations, and clinical trial sponsors. The company's core offering combines artificial intelligence, natural language query processing, and streaming video media to deliver interactive, personalized patient education where patients can ask questions in their own words and receive pre-recorded, IRB-approved video responses from clinicians and healthcare experts. Its proprietary Synthetic Interview technology, developed as a Carnegie Mellon University spin-out, forms the technical foundation and is deployed under the Fit For Surgery, Chronic Care Management, ONS Oral Chemo Guide, Supportive Care Options, SBIRTCoach, and Custom Conversations products.
The platform is sold primarily through direct enterprise sales to hospitals and healthcare enterprises, with each deployment custom-branded and tailored to specific procedures, medications, or patient populations. Named deployments include Cleveland Clinic's Interactive Heart Surgery Program, Allegheny Health Network's Fit For Surgery cardiac platform, and the Oncology Nursing Society's oral chemotherapy patient education program. Revenue is generated through enterprise platform licensing (subscription/recurring), custom educational content development services, and licensing partnerships including an exclusive strategic alliance with MMG (a Ketchum/Omnicom global health communications company) for global distribution of the Custom Conversations clinical trial education platform.
MedRespond operates from a Pittsburgh headquarters and a Cleveland regional office opened in October 2017 at the Global Center for Health Innovation to access the Northeast Ohio biomedical ecosystem. The company has limited disclosed outside capital — a $50,000 first-place prize from the 2017 Medical Capital Innovation Competition and $50,000 from Innovation Works in 2020 — and counts roughly 11-50 employees with no disclosed revenue. Notable operational metrics include 75-90 minutes average patient engagement per procedure, 100% patient-reported experience improvement, and a 50% reduction in post-discharge medical expenses in the first 30 days after surgery for platform users.
MedRespond firmographics
Firmographics- Name
- MedRespond
- Legal name
- MedRespond, LLC
- Website
- https://medrespond.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MedRespond provides AI-powered conversational patient engagement platforms for hospitals, health systems, clinical trial sponsors, and advocacy groups, enabling patients to ask questions in natural language and receive personalized IRB-approved video responses through its proprietary Synthetic Interview technology.
- Ownership category
- akta.pro rank
MedRespond industry classification
Industry- Product category
- Healthcare Patient Engagement Software
- NAICS
- All Other Outpatient Care Centers (621498)
- SIC
- Services-Prepackaged Software (7372), Services-Health Services (8000)
- akta.pro primary industry
- Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ)
- akta.pro secondary industries
- Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF), Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD), Patient Communications (Reminders/Confirmations/Recalls) (HLACADAH), Care Management & Coordination Platforms (case/disease management workflows) (HLACAHAD)
Keywords
Where MedRespond is headquartered
LocationHeadquarters
- HQ city
- Pittsburgh
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
MedRespond business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Enterprise Platform Licensing: MedRespond provides custom branded conversational patient engagement platforms to healthcare enterprises. Revenue is derived from platform licensing fees, likely subscription or enterprise contract based, customized per client.
- Custom Educational Content Development: The company creates custom educational programs tailored to specific client needs (surgical platforms, chronic care programs, clinical trial education). Revenue generated through content development and deployment services for healthcare clients.
- MMG Strategic Partnership - Custom Conversations: Exclusive strategic partnership with MMG for clinical trial patient education. MedRespond provides the Custom Conversations technology platform while MMG handles global clinical trial patient recruitment and retention, generating revenue through this channel partnership.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
MedRespond product offering
Product offeringCore offering
MedRespond provides an AI-driven Conversational Patient Engagement Platform that lets patients ask questions in their own words and receive prerecorded, IRB-approved video responses, branded and customized for each healthcare client. The company builds and licenses vertical-specific solutions spanning surgical preparation and recovery, chronic care management, oncology education, clinical trial recruitment, SBIRT training, and supportive/end-of-life care for hospitals, health systems, advocacy groups, pharmacy retailers, and clinical trial sponsors.
Product overview
MedRespond is a healthcare communications company offering a unified Conversational Patient Engagement Platform that combines artificial intelligence, search, and streaming media. The platform includes specialized modules for Surgical Care and Chronic Care Management as the core solutions, supplemented by targeted programs including Fit For Surgery™ for cardiac surgery patients, SBIRTCoach™ and AlcoholSBIRT™ for substance abuse training, ONS Oral Chemo Guide for oncology education, Supportive Care Options for end-of-life decisions, and Custom Conversations for clinical trial recruitment and retention. All solutions leverage synthetic interview technology to deliver personalized video-based responses to natural language patient queries.
Differentiator
Problem solved
Functional benefit
Products and services
- Surgical Care Platform AI-driven, patient-centered platform supporting patients and caregivers through pre- and post-operative care with conversational video education, customizable with hospital branding and surgical messaging.
- Chronic Care Management AI-driven platform providing patient-centered support from chronic disease education to medication adherence and weight management goal-setting, available 24/7 via smartphone, tablet, or PC.
- Custom Conversations Clinical-trial patient education platform combining video, natural language query, and internet access so patients and caregivers can drive customized online learning interactions and receive IRB-approved video responses.
- Fit For Surgery Conversational Patient Engagement System built for Allegheny Health Network cardiac surgery patients, reinforcing pre-surgery preparation, day-of-surgery expectations, and recovery information with family caregiver access.
- SBIRTCoach Interactive training program for Screening, Brief Intervention and Referral to Treatment using Synthetic Interview technology, with CE, CME, and Continuing Social Work credits available; licensed individually or on an enterprise basis.
- AlcoholSBIRT Enterprise or individually licensed SBIRT training program using Synthetic Interview technology to convert didactic curriculum into interactive, conversational training.
- ONS Oral Chemo Guide Oncology Nursing Society patient education program providing 24/7 answers about oral chemotherapy drugs and the cancer journey for patients and families.
- Supportive Care Options Patient education program initiating dialogue about terminal illness decisions including prognosis response, care options, treatment documentation, finding support, and financial concerns, with a printable decision support tool.
Quantifiable outcome
- Patients spend 75-90 minutes on average watching conversational videos before and after procedures, indicating deep engagement.
- +3 more outcomes
Companies that use MedRespond
Customer profileNamed customers6 records
Segments6 records
Ideal customer profiles4 records
MedRespond technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature6 records
MedRespond partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- BioEnterprisecoreBioEnterprise, a healthcare venture development organization, led strategy at the Global Center for Health Innovation and worked with MedRespond to establish its Cleveland office. BioEnterprise helped lay the foundation for MedRespond's expansion into Cleveland and the Northeast Ohio healthcare ecosystem, providing mentorship, industry connections, and healthcare collaborator access.
- Global Center for Health Innovation (GCHI)minorMedRespond opened a Cleveland office in the Global Center for Health Innovation, gaining access to Northeast Ohio's vibrant entrepreneurial community and healthcare industry assets. The GCHI provides a hub for healthcare technology companies to connect with mentors, industry collaborators, and customers in the region.
- Pittsburgh Technology CouncilminorPittsburgh Technology Council recognized MedRespond as a finalist in the Tech 50 Innovator of the Year in Healthcare Technology category, providing regional industry recognition and visibility within Pittsburgh's technology community.
- HIMSS (Healthcare Information and Management Systems Society)minorHIMSS co-sponsored the Medical Capital Innovation Competition at the HIMSS Innovation Center, which awarded MedRespond first place and provided access to the HIMSS Innovation Center facilities and healthcare industry network.
- MMG (Ketchum/Omnicom)coreExclusive strategic partnership between MedRespond and MMG to introduce Custom Conversations, a clinical-trial patient education platform combining MedRespond's synthetic interview technology with MMG's global clinical trial patient recruitment and retention services. The platform enables patients exploring clinical trial options to drive customized online learning interactions and receive IRB-approved video responses. MMG serves pharmaceutical clients in over 70 countries, and MedRespond provides the underlying technology platform.
- Carnegie Mellon University (CMU)coreMedRespond originated as a Carnegie Mellon University academic spin-out. The company continues to license technologies from CMU and maintains a collaborative relationship with the university. CMU's advanced synthetic interview technology forms the foundation of MedRespond's platform. MedRespond often collaborates with CMU faculty and staff for innovation and technology development.
Scale indicators3 records
Recent moves7 records
Expansion highlights6 records
MedRespond competitors and assessment
Company assessmentDirect peers
- CipherHealth: Direct peer providing patient engagement, communication, and rounding solutions to hospitals and health systems. CipherHealth's automated outreach and education workflows overlap with MedRespond's conversational patient engagement platform, targeting similar nursing and care coordination buyers.
- GetWellNetwork: Direct peer offering enterprise patient engagement and education platforms to hospitals and health systems. Both MedRespond and GetWellNetwork deploy branded interactive patient experiences across the care continuum and compete for the same hospital IT budgets.
- Force Therapeutics: Direct peer focused on digital care pathways for musculoskeletal and surgical patients, delivering video-based education and remote monitoring pre- and post-procedure. Closely comparable to MedRespond's Surgical Care Platform and Fit For Surgery module.
- Conversa Health: Direct peer offering an AI-driven conversational patient engagement platform for healthcare enterprises. Both companies pair natural language patient interactions with curated clinical content and target provider organizations for chronic care and post-discharge engagement.
Broad incumbents
- Krames (Staywell/WebMD): Established patient education content and platform provider owned by Internet Brands/WebMD. Krames competes with MedRespond on the patient education layer within health systems, though with more traditional video and print content rather than conversational AI delivery.
- PatientPoint: Established patient engagement incumbent delivering point-of-care education and digital tools across physician offices and health systems. While broader in scope (including waiting room and exam room touchpoints), PatientPoint overlaps with MedRespond's hospital patient education offerings.
- Wolters Kluwer (Emmi Solutions): Broader incumbent offering multimedia patient engagement, education, and consent solutions through its Emmi Solutions business. Wolters Kluwer's scale and UpToDate clinical content provide a large-platform alternative to MedRespond's conversational video approach.
- Phreesia: Public, scaled patient intake and engagement platform used across large health systems for check-in, education, and messaging. Phreesia competes for the same healthcare enterprise patient communication budgets as MedRespond but at significantly greater scale and capital base.
Emerging players
- SeamlessMD: Emerging peer providing digital care journeys for surgery and chronic care patients with interactive education and remote monitoring. Comparable to MedRespond's surgical and chronic care management offerings, targeting similar perioperative patient engagement workflows.
- Health Recovery Solutions: Emerging peer offering remote patient monitoring and patient engagement tools for hospitals and home health. While more RPM-focused, it overlaps with MedRespond's chronic care management and post-discharge engagement use cases.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
MedRespond social profiles
Digital presenceMedRespond financial estimates
Financial estimateRevenue estimate
Valuation estimate
MedRespond leadership team
Management profileNumber of profiles
Profiles2 records
MedRespond funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MedRespond M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MedRespond
What does MedRespond do?
MedRespond provides an AI-driven Conversational Patient Engagement Platform that lets patients ask questions in their own words and receive prerecorded, IRB-approved video responses, branded and customized for each healthcare client. The company builds and licenses vertical-specific solutions spanning surgical preparation and recovery, chronic care management, oncology education, clinical trial recruitment, SBIRT training, and supportive/end-of-life care for hospitals, health systems, advocacy groups, pharmacy retailers, and clinical trial sponsors.
Is MedRespond a public or private company?
MedRespond is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MedRespond founded?
MedRespond was founded in 2000. It employs 11 to 50 people.
Where is MedRespond based?
MedRespond is headquartered in Pittsburgh, United States, in the North America region.
How does MedRespond make money?
Three revenue lines are on record. Enterprise Platform Licensing is the primary driver. The others are custom Educational Content Development and MMG Strategic Partnership - Custom Conversations.
Who are MedRespond's main competitors?
Direct peers on record are CipherHealth, GetWellNetwork, Force Therapeutics and Conversa Health. Broad incumbents are Krames (Staywell/WebMD), PatientPoint, Wolters Kluwer (Emmi Solutions) and Phreesia. Emerging players are SeamlessMD and Health Recovery Solutions.
Does MedRespond have an API?
No public API is recorded for MedRespond.
What industry is MedRespond in?
MedRespond's product category is Healthcare Patient Engagement Software. Its primary akta.pro industry code is HLALABAJ, Patient Engagement, Education & Messaging Platforms (portal/CRM integrated), with a secondary code of HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs). Its NAICS code is 621498 and its SIC code is 7372.